Code is covered without prior authorization (high confidence)
Documentation Required
Pre-operative assessment of air-bone gap: documented air-bone gap measurements to predict potential BAHA benefit and to support selection (noted as useful in predicting whether speech recognition may improve or deteriorate with BAHA vs air-conduction aids).
Trials of non-implantable options where appropriate: documentation of trials with alternatives (e.g., CROS hearing aids, Softband/Headband BAHA/processor on Softband) when clinically indicated and as part of comparative assessment (some studies trialed CROS prior to BAHA).
Device-specific criteria documentation: for bilateral fittings document symmetry of BC thresholds (interaural difference <10 dB average or <15 dB at individual frequencies); for SSD document normal hearing in the better ear (AC PTA ≤ 20 dB HL).
Key Coverage Criteria
Bilateral symmetric moderate-to-severe conductive or mixed hearing loss (bilateral implant is intended for bilaterally symmetric losses).
Patients who have an almost instantaneous skin reaction to ear molds (i.e., cannot tolerate conventional earmolds/air-conduction aids).
Otosclerosis as a third treatment option for patients who cannot or will not undergo stapedectomy.
Children: bilateral BAHAs in children with bilateral conductive hearing loss and unilateral BAHA or unilateral hearing aid in children with unilateral conductive hearing loss (studies report audiologic benefits and high patient/parent satisfaction).
Patients with mixed hearing loss and a significant air-bone gap: BAHA may provide better speech recognition than BTE devices when the average air-bone gap exceeds approximately 30–35 dB (some data suggest >35 dB; earlier reports cited 25–30 dB).
Bonebridge System (MED-EL) — FDA/cleared indications: individuals 12 years of age or older with conductive or mixed hearing loss who can still benefit from amplification (PTA bone conduction threshold at 0.5, 1, 2, 3 kHz ≤ 45 dB HL); bilateral fitting intended for symmetric conductive/mixed loss (interaural BC difference <10 dB average or <15 dB at individual frequencies); individuals with SSD where the hearing ear AC PTA (0.5,1,2,3 kHz) ≤ 20 dB HL.
Ask Verity about documentation requirements, denial risks, or coverage in your state.
Age documentation: patient age consistent with device labeling (e.g., BAHA ≥ 5 years; Bonebridge ≥ 12 years) must be recorded.
Clinical history and contraindications: documentation that conventional air-conduction hearing aids are contraindicated, not tolerated, or ineffective (e.g., chronic ear disease, intolerance to earmolds), or rationale for choosing implantable bone conduction device.
Surgical documentation: evidence that implantation is performed by appropriately trained staff in an operating room (when implantation is used) and any intraoperative findings or modifications (e.g., bone smoothing, implant placement) as indicated by clinical narrative.